Thu, August 01, 2019
Decision; UK Anti-Doping (UKAD) v Todd James
To optimise for archiving, the original image and related documents associated with this article have been removed.
A decision in the case of the UK Anti-Doping (UKAD) v Todd James has been published by the National Anti-Doping Panel (NADP).
On 27 October 2018 Todd James, a registered player of Welsh Rugby Union, was selected for In-Competition testing following the WRU Premiership match between Pontypridd RFC and Cross Keys RFC. The urine sample returned an Adverse Analytical Finding for the presence of ostarine, a non-Specified substance listed on the WADA Prohibited List under section S1.2 ‘Other Anabolic Agents’ and prohibited at all times. Mr James was subsequently charged with a breach of Anti-Doping Rule Article 2.1 for the Presence of a Prohibited Substance. Mr James admitted the Anti-Doping Rule Violation (ADRV), but was unable to provide the required evidence to establish the route of ingestion and therefore show the Tribunal that ingestion had not been intentional.
The Tribunal imposed a period of ineligibility of 4 years, running from 14 December 2018, the date of Provisional Suspension, until midnight on 13 December 2022.
The full NADP decision can be accessed via the related links tab on the right-hand side.
The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping, who are responsible for investigating, charging and prosecuting cases before the NADP.
